General Biophysics was formed in 2017 to focus on the medical potential of xenon gas, particularly in treating ...

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative ...

Leaders must restore domestic tranquility For multiple reasons, I thank God that Donald Trump was not killed, injured or shot ...

In an era in the 1970s where stand-up comedy could be a path to superstardom ... Rowlands died on August 14 following a battle with Alzheimer's. Richard Simmons would use his drive for weight ...

plasma microRNAome evaluation helps predict which aging individuals concerned about cognitive decline will progress to develop Alzheimer's. These findings provide a path toward a better ...

(RTTNews) - Hoth Therapeutics, Inc. (HOTH) Tuesday announced promising preclinical results for its investigational Alzheimer's drug, HT-ALZ. The company's shares were rising more than 15 percent ...

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel ...

(RTTNews) - INmune Bio, Inc. (INMB), Tuesday announced additional analysis of blinded data from AD02 Phase II Alzheimer's Disease, demonstrating exceptional performance of the novel cognitive ...

Alzheimer’s disease (Alzheimer’s) is conceptualized as a progressive consequence of two hallmark pathological changes in gray matter, in particular, extracellular amyloid plaques and neurofibrillary ...

The study, published in Alzheimer's & Dementia, highlights a potential commonality in brain disorders across these conditions that could pave the way for new avenues in research and treatment.

A new study has found an answer for a long-lasting question in aging research - Is Alzheimer’s disease-dementia a form of accelerated aging or is there a different path that can lead us to ...